4
Changes in Ownership
MAIA Biotechnology, Inc. Filed Acc 0001127602-23-017885
Options or other derivatives
- Chief Medical Officer acquired 87,495 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Obrocea Mihail Chief Medical Officer | 2023-05-31 | Grant or award · Stock Options | +87,495 | 87,495 | D: show line 1 in the form |
Loading xslF345X04/form4.xml…